| 1 |
35072975 | Effects of pemafibrate on primary biliary cholangitis with dyslipidemia. | 2022 Jun |
1 |
| 2 |
33806503 | Real-World Clinical Management of Patients with Primary Biliary Cholangitis-A Retrospective Multicenter Study from Germany. | 2021 Mar 4 |
1 |
| 3 |
31077509 | Biochemical and plasma lipid responses to pemafibrate in patients with primary biliary cholangitis. | 2019 Oct |
1 |
| 4 |
29016567 | Effects of Bezafibrate on Outcome and Pruritus in Primary Biliary Cholangitis With Suboptimal Ursodeoxycholic Acid Response. | 2018 Jan |
1 |
| 5 |
20127368 | Bezafibrate for the treatment of primary sclerosing cholangitis. | 2010 Jul |
2 |
| 6 |
15288014 | Prospective randomized crossover trial of combination therapy with bezafibrate and UDCA for primary biliary cirrhosis. | 2004 Aug |
1 |
| 7 |
12825134 | Bezafibrate treatment: a new medical approach for PBC patients? | 2003 |
2 |
| 8 |
8937134 | A lipid lowering drug (bezafibrate) has a favorable effect on liver enzymes (Al-P and gamma-GTP). | 1996 Oct |
1 |
| 9 |
8102192 | The effect of bezafibrate treatment on serum alkaline phosphatase isoenzyme activities. | 1993 Jul |
5 |